Intrabone gene therapy with autologous HSCs for transfusion-dependent beta-thalassemia: phase I/II Jan. 28, 2019
Protagonist Therapeutics initiates phase II study of PTG-300 in patients with beta-thalassemia Jan. 11, 2019
Results presented from phase III CASSINI study evaluating rivaroxaban thromboprophylaxis Jan. 3, 2019
Sustained clinical benefit in patients with beta-thalassemia following LentiGlobin gene therapy Dec. 28, 2018
RSS